Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating a vaccine therapy for patients with recurrent soft tissue sarcoma. The sponsor associated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED